[2]
Freifeld AG,Bow EJ,Sepkowitz KA,Boeckh MJ,Ito JI,Mullen CA,Raad II,Rolston KV,Young JA,Wingard JR,Infectious Diseases Society of Americaa., Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Feb 15;
[PubMed PMID: 21205990]
Level 1 (high-level) evidence
[3]
Heinz WJ,Buchheidt D,Christopeit M,von Lilienfeld-Toal M,Cornely OA,Einsele H,Karthaus M,Link H,Mahlberg R,Neumann S,Ostermann H,Penack O,Ruhnke M,Sandherr M,Schiel X,Vehreschild JJ,Weissinger F,Maschmeyer G, Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of hematology. 2017 Nov;
[PubMed PMID: 28856437]
[4]
Laupland KB,Shahpori R,Kirkpatrick AW,Ross T,Gregson DB,Stelfox HT, Occurrence and outcome of fever in critically ill adults. Critical care medicine. 2008 May;
[PubMed PMID: 18434882]
[5]
Lee BH,Inui D,Suh GY,Kim JY,Kwon JY,Park J,Tada K,Tanaka K,Ietsugu K,Uehara K,Dote K,Tajimi K,Morita K,Matsuo K,Hoshino K,Hosokawa K,Lee KH,Lee KM,Takatori M,Nishimura M,Sanui M,Ito M,Egi M,Honda N,Okayama N,Shime N,Tsuruta R,Nogami S,Yoon SH,Fujitani S,Koh SO,Takeda S,Saito S,Hong SJ,Yamamoto T,Yokoyama T,Yamaguchi T,Nishiyama T,Igarashi T,Kakihana Y,Koh Y,Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group., Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Critical care (London, England). 2012 Feb 28;
[PubMed PMID: 22373120]
Level 2 (mid-level) evidence
[6]
Young PJ,Saxena M,Beasley R,Bellomo R,Bailey M,Pilcher D,Finfer S,Harrison D,Myburgh J,Rowan K, Early peak temperature and mortality in critically ill patients with or without infection. Intensive care medicine. 2012 Jan 31;
[PubMed PMID: 22290072]
[7]
Sundén-Cullberg J,Rylance R,Svefors J,Norrby-Teglund A,Björk J,Inghammar M, Fever in the Emergency Department Predicts Survival of Patients With Severe Sepsis and Septic Shock Admitted to the ICU. Critical care medicine. 2017 Apr;
[PubMed PMID: 28141683]
[8]
Circiumaru B,Baldock G,Cohen J, A prospective study of fever in the intensive care unit. Intensive care medicine. 1999 Jul;
[PubMed PMID: 10470569]
[9]
Barie PS,Hydo LJ,Eachempati SR, Causes and consequences of fever complicating critical surgical illness. Surgical infections. 2004 Summer;
[PubMed PMID: 15353111]
[11]
Reaven NL,Lovett JE,Funk SE, Brain injury and fever: hospital length of stay and cost outcomes. Journal of intensive care medicine. 2009 Mar-Apr
[PubMed PMID: 19188268]
[12]
Leon LR, Invited review: cytokine regulation of fever: studies using gene knockout mice. Journal of applied physiology (Bethesda, Md. : 1985). 2002 Jun;
[PubMed PMID: 12015385]
[13]
Netea MG,Kullberg BJ,Van der Meer JW, Circulating cytokines as mediators of fever. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Oct;
[PubMed PMID: 11113021]
[14]
Katsuura G,Arimura A,Koves K,Gottschall PE, Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. The American journal of physiology. 1990 Jan;
[PubMed PMID: 1967907]
[16]
O'Grady NP,Barie PS,Bartlett JG,Bleck T,Carroll K,Kalil AC,Linden P,Maki DG,Nierman D,Pasculle W,Masur H,American College of Critical Care Medicine.,Infectious Diseases Society of America., Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Critical care medicine. 2008 Apr;
[PubMed PMID: 18379262]
[20]
Singer M,Deutschman CS,Seymour CW,Shankar-Hari M,Annane D,Bauer M,Bellomo R,Bernard GR,Chiche JD,Coopersmith CM,Hotchkiss RS,Levy MM,Marshall JC,Martin GS,Opal SM,Rubenfeld GD,van der Poll T,Vincent JL,Angus DC, The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;
[PubMed PMID: 26903338]
Level 3 (low-level) evidence
[21]
Bouadma L,Luyt CE,Tubach F,Cracco C,Alvarez A,Schwebel C,Schortgen F,Lasocki S,Veber B,Dehoux M,Bernard M,Pasquet B,Régnier B,Brun-Buisson C,Chastre J,Wolff M,PRORATA trial group., Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet (London, England). 2010 Feb 6;
[PubMed PMID: 20097417]
Level 1 (high-level) evidence
[22]
Huang HB,Peng JM,Weng L,Wang CY,Jiang W,Du B, Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Annals of intensive care. 2017 Nov 22;
[PubMed PMID: 29168046]
Level 1 (high-level) evidence
[23]
Meisner M,Rauschmayer C,Schmidt J,Feyrer R,Cesnjevar R,Bredle D,Tschaikowsky K, Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive care medicine. 2002 Aug;
[PubMed PMID: 12185431]
[24]
Heussel CP,Kauczor HU,Heussel GE,Fischer B,Begrich M,Mildenberger P,Thelen M, Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Mar;
[PubMed PMID: 10071269]
[25]
Kluger MJ,Kozak W,Conn CA,Leon LR,Soszynski D, The adaptive value of fever. Infectious disease clinics of North America. 1996 Mar;
[PubMed PMID: 8698984]
[26]
Hasday JD,Fairchild KD,Shanholtz C, The role of fever in the infected host. Microbes and infection. 2000 Dec;
[PubMed PMID: 11165933]
[27]
Young PJ,Saxena M, Fever management in intensive care patients with infections. Critical care (London, England). 2014 Mar 18;
[PubMed PMID: 25029624]
[28]
Bernard GR,Wheeler AP,Russell JA,Schein R,Summer WR,Steinberg KP,Fulkerson WJ,Wright PE,Christman BW,Dupont WD,Higgins SB,Swindell BB, The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. The New England journal of medicine. 1997 Mar 27;
[PubMed PMID: 9070471]
[30]
Broessner G,Beer R,Lackner P,Helbok R,Fischer M,Pfausler B,Rhorer J,Küppers-Tiedt L,Schneider D,Schmutzhard E, Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009 Dec;
[PubMed PMID: 19762706]
Level 1 (high-level) evidence
[31]
Broessner G,Lackner P,Fischer M,Beer R,Helbok R,Pfausler B,Schneider D,Schmutzhard E, Influence of prophylactic, endovascularly based normothermia on inflammation in patients with severe cerebrovascular disease: a prospective, randomized trial. Stroke. 2010 Dec;
[PubMed PMID: 21030704]
Level 1 (high-level) evidence
[32]
Greer DM,Funk SE,Reaven NL,Ouzounelli M,Uman GC, Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke. 2008 Nov;
[PubMed PMID: 18723420]
Level 1 (high-level) evidence
[33]
Young PJ,Bailey MJ,Bass F,Beasley RW,Freebairn RC,Hammond NE,van Haren FMP,Harward ML,Henderson SJ,Mackle DM,McArthur CJ,McGuinness SP,Myburgh JA,Saxena MK,Turner AM,Webb SAR,Bellomo R,REACTOR investigators.,ANZICS Clinical Trials Group., Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial. Intensive care medicine. 2019 Oct;
[PubMed PMID: 31576434]
Level 1 (high-level) evidence
[34]
Schortgen F,Clabault K,Katsahian S,Devaquet J,Mercat A,Deye N,Dellamonica J,Bouadma L,Cook F,Beji O,Brun-Buisson C,Lemaire F,Brochard L, Fever control using external cooling in septic shock: a randomized controlled trial. American journal of respiratory and critical care medicine. 2012 May 15;
[PubMed PMID: 22366046]
Level 1 (high-level) evidence
[35]
Young P,Saxena M,Bellomo R,Freebairn R,Hammond N,van Haren F,Holliday M,Henderson S,Mackle D,McArthur C,McGuinness S,Myburgh J,Weatherall M,Webb S,Beasley R,HEAT Investigators.,Australian and New Zealand Intensive Care Society Clinical Trials Group., Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. The New England journal of medicine. 2015 Dec 3;
[PubMed PMID: 26436473]
[36]
Drewry AM,Ablordeppey EA,Murray ET,Stoll CRT,Izadi SR,Dalton CM,Hardi AC,Fowler SA,Fuller BM,Colditz GA, Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis. Critical care medicine. 2017 May;
[PubMed PMID: 28221185]
Level 1 (high-level) evidence
[37]
Kelly SJ,Moran JL,Williams PJ,Burns K,Rowland A,Miners JO,Peake SL, Haemodynamic effects of parenteral vs. enteral paracetamol in critically ill patients: a randomised controlled trial. Anaesthesia. 2016 Oct;
[PubMed PMID: 27611038]
Level 1 (high-level) evidence
[38]
Cantais A,Schnell D,Vincent F,Hammouda Z,Perinel S,Balichard S,Abroug F,Zeni F,Meziani F,Bornstain C,Darmon M, Acetaminophen-Induced Changes in Systemic Blood Pressure in Critically Ill Patients: Results of a Multicenter Cohort Study. Critical care medicine. 2016 Dec;
[PubMed PMID: 27414476]
[39]
Kalil AC,Metersky ML,Klompas M,Muscedere J,Sweeney DA,Palmer LB,Napolitano LM,O'Grady NP,Bartlett JG,Carratalà J,El Solh AA,Ewig S,Fey PD,File TM Jr,Restrepo MI,Roberts JA,Waterer GW,Cruse P,Knight SL,Brozek JL, Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Sep 1;
[PubMed PMID: 27418577]
Level 1 (high-level) evidence
[41]
Manian FA, IDSA guidelines for the diagnosis and management of intravascular catheter-related bloodstream infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Dec 1;
[PubMed PMID: 19891568]
[42]
Hooton TM,Bradley SF,Cardenas DD,Colgan R,Geerlings SE,Rice JC,Saint S,Schaeffer AJ,Tambayh PA,Tenke P,Nicolle LE,Infectious Diseases Society of America., Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Mar 1;
[PubMed PMID: 20175247]
Level 1 (high-level) evidence
[43]
Cremasco MF,Wenzel F,Zanei SS,Whitaker IY, Pressure ulcers in the intensive care unit: the relationship between nursing workload, illness severity and pressure ulcer risk. Journal of clinical nursing. 2013 Aug;
[PubMed PMID: 23216694]
[44]
Frankel H,Sperry J,Kaplan L, Risk factors for pressure ulcer development in a best practice surgical intensive care unit. The American surgeon. 2007 Dec;
[PubMed PMID: 18186374]
[45]
Slowikowski GC,Funk M, Factors associated with pressure ulcers in patients in a surgical intensive care unit. Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. 2010 Nov-Dec;
[PubMed PMID: 21076261]
[46]
Barie PS,Eachempati SR, Acute acalculous cholecystitis. Gastroenterology clinics of North America. 2010 Jun;
[PubMed PMID: 20478490]
[47]
Balsalobre Filho LL,Vieira FM,Stefanini R,Cavalcante R,Santos Rde P,Gregório LC, [Nosocomial sinusitis in an intensive care unit: a microbiological study]. Brazilian journal of otorhinolaryngology. 2011 Jan-Feb;
[PubMed PMID: 21340197]
[48]
Zinreich SJ, Rhinosinusitis: radiologic diagnosis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 1997 Sep;
[PubMed PMID: 9334785]
[49]
Starr J, Clostridium difficile associated diarrhoea: diagnosis and treatment. BMJ (Clinical research ed.). 2005 Sep 3;
[PubMed PMID: 16141157]
[50]
Roush MK,Nelson KM, Understanding drug-induced febrile reactions. American pharmacy. 1993 Oct;
[PubMed PMID: 8237783]
Level 3 (low-level) evidence
[52]
Young PJ,Bellomo R,Bernard GR,Niven DJ,Schortgen F,Saxena M,Beasley R,Weatherall M, Fever control in critically ill adults. An individual patient data meta-analysis of randomised controlled trials. Intensive care medicine. 2019 Apr;
[PubMed PMID: 30741326]
Level 1 (high-level) evidence
[53]
Sakkat A,Alquraini M,Aljazeeri J,Farooqi MAM,Alshamsi F,Alhazzani W, Temperature control in critically ill patients with fever: A meta-analysis of randomized controlled trials. Journal of critical care. 2021 Feb;
[PubMed PMID: 33157310]
Level 2 (mid-level) evidence
[54]
Manthous CA,Hall JB,Olson D,Singh M,Chatila W,Pohlman A,Kushner R,Schmidt GA,Wood LD, Effect of cooling on oxygen consumption in febrile critically ill patients. American journal of respiratory and critical care medicine. 1995 Jan;
[PubMed PMID: 7812538]
[55]
Bao L,Chen D,Ding L,Ling W,Xu F, Fever burden is an independent predictor for prognosis of traumatic brain injury. PloS one. 2014;
[PubMed PMID: 24626046]
[56]
Badawi N,Kurinczuk JJ,Keogh JM,Alessandri LM,O'Sullivan F,Burton PR,Pemberton PJ,Stanley FJ, Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ (Clinical research ed.). 1998 Dec 5;
[PubMed PMID: 9836653]
Level 2 (mid-level) evidence